|
Eine Ebene nach oben |
Gruppiert nach: Dokumententyp |
Veröffentlichungsdatum
Anzahl der Publikationen: 8
2022
Rusconi, Chiara; Cheah, Chan Y.; Eyre, Toby A.; Tucker, David; Klener, Pavel; Gine, Eva; Crucitti, Lara; Muzi, Cristina; Iadecola, Sara; Infante, Gabriele; Bernard, Sophie; Auer, Rebecca L.; Pagani, Chiara; Duglosz-Danecka, Monika; Mocikova, Heidi; Meerten, Tom van; Cencini, Emanuele; Marin-Niebla, Ana; Williams, Michael E.; Angelillo, Piera; Nicoli, Paolo; Arcari, Annalisa; Morello, Lucia; Mannina, Donato; Vitagliano, Orsola; Sartori, Roberto; Chiappella, Annalisa; Sciarra, Roberta; Stefani, Piero M.; Dreyling, Martin; Seymour, John F. und Visco, Carlo
(2022):
Ibrutinib improves survival compared with chemotherapy in mantle cell lymphoma with central nervous system relapse.
In: Blood, Bd. 140, Nr. 17: S. 1907-1916
2020
Mir, Farheen; Mattiello, Federico; Grigg, Andrew; Herold, Michael; Hiddemann, Wolfgang; Marcus, Robert; Seymour, John F.; Bolen, Christopher R.; Knapp, Andrea; Nielsen, Tina und Casulo, Carla
(2020):
Follicular Lymphoma Evaluation Index (FLEX): A new clinical prognostic model that is superior to existing risk scores for predicting progression-free survival and early treatment failure after frontline immunochemotherapy.
In: American Journal of Hematology, Bd. 95, Nr. 12: S. 1503-1510
2019
Jamois, Candice; Gibiansky, Ekaterina; Gibiansky, Leonid; Buchheit, Vincent; Sahin, Denis; Cartron, Guillaume; Marcus, Robert; Hiddemann, Wolfgang; Seymour, John F.; Strefford, Jonathan C.; Hargreaves, Chantal E.; Meneses-Lorente, Georgina; Frey, Nicolas und Fingerle-Rowson, Guenter
(2019):
Role of obinutuzumab exposure on clinical outcome of follicular lymphoma treated with first-line immunochemotherapy.
In: British Journal of Clinical Pharmacology, Bd. 85, Nr. 7: S. 1495-1506
Seymour, John F.; Marcus, Robert; Davies, Andrew; Gallop-Evans, Eve; Grigg, Andrew; Haynes, Andrew; Herold, Michael; Illmer, Thomas; Nilsson-Ehle, Herman; Soekler, Martin; Duenzinger, Ulrich; Nielsen, Tina; Launonen, Aino und Hiddemann, Wolfgang
(2019):
Association of early disease progression and very poor survival in the GALLIUM study in follicular lymphoma: benefit of obinutuzumab in reducing the rate of early progression.
In: Haematologica, Bd. 104, Nr. 6: S. 1202-1208
2018
Hiddemann, Wolfgang; Barbui, Anna Maria; Canales, Miguel A.; Cannell, Paul K.; Collins, Graham P.; Dürig, Jan; Forstpointner, Roswitha; Herold, Michael; Hertzberg, Mark; Klanova, Magdalena; Radford, John; Seymour, John F.; Tobinai, Kensei; Trotman, Judith; Burciu, Alis; Fingerle-Rowson, Günter; Wolbers, Marcel; Nielsen, Tina und Marcus, Robert E.
(2018):
Immunochemotherapy With Obinutuzumab or Rituximab for Previously Untreated Follicular Lymphoma in the GALLIUM Study: Influence of Chemotherapy on Efficacy and Safety.
In: Journal of Clinical Oncology, Bd. 36, Nr. 23: S. 2395-2404
[PDF, 904kB]
Tam, Constantine S.; Anderson, Mary Ann; Pott, Christiane; Agarwal, Rishu; Handunnetti, Sasanka; Hicks, Rodney J.; Burbury, Kate; Turner, Gillian; Di Iulio, Juliana; Bressel, Mathias; Westerman, David; Lade, Stephen; Dreyling, Martin; Dawson, Sarah-Jane; Dawson, Mark A.; Seymour, John F. und Roberts, Andrew W.
(2018):
Ibrutinib plus Venetoclax for the Treatment of Mantle-Cell Lymphoma.
In: New England Journal of Medicine, Bd. 378, Nr. 13: S. 1211-1223
2017
Marcus, Robert; Seymour, John F. und Hiddemann, Wolfgang
(2017):
Obinutuzumab Treatment of Follicular Lymphoma REPLY.
In: New England Journal of Medicine, Bd. 377, Nr. 26: S. 2605-2606
Gascoyne, Randy D.; Nadel, Bertrand; Pasqualucci, Laura; Fitzgibbon, Jude; Payton, Jacqueline E.; Melnick, Ari; Weigert, Oliver; Tarte, Karin; Gribben, John G.; Friedberg, Jonathan W.; Seymour, John F.; Cavalli, Franco und Zucca, Emanuele
(2017):
Follicular lymphoma: State-of-the-art ICML workshop in Lugano 2015.
In: Hematological Oncology, Bd. 35, Nr. 4: S. 397-407